Overview
- The IV International Congress “Nuclear Medicine‑2025” convened in Saint Petersburg on December 11–13 with more than 500 specialists and international participation.
- Health Minister Mikhail Murashko reported about 1 million diagnostic studies annually and nearly 28,000 patients treated with radiopharmaceuticals, with plans to lift diagnostic use by over 16% and therapeutic use by over 60% by 2030.
- Modernization plans include re‑equipping 31 federal facilities, the introduction of 83 heavy devices, and new radiotherapy capabilities at 107 regional organizations across 70 regions by 2030.
- Rosatom highlighted global isotope supply to more than 50 countries and the construction of a GMP‑standard radiopharmaceutical plant in Obninsk, alongside reports on expanded production of medical isotopes and photoneutron technologies.
- Speakers warned of a shortage of qualified radiopharmacists and misaligned training and professional standards, urging harmonization with international classifications and expanded education pathways as Russia now counts 62 registered radiopharmaceuticals with a growing therapeutic share.